4D Molecular Therapeutics, Inc. financial statements, including revenue, expenses, and profit

The total revenue of FDMT for the last quarter is 1.00 k USD, and it's 66.67% lower compared to the previous quarter. The net income of Q4 24 is -49.67 M USD.